August 2015 Briefing – Rheumatology
Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for August 2015. This roundup includes the latest...
Multidisciplinary Rehab Tops CBT for Chronic Fatigue Syndrome
Significantly more effective for reducing fatigue at 52 weeks versus cognitive behavioral therapy
FDA Warns of Joint Pain Tied to DPP-4 Inhibitors
Agency advises users with such symptoms to contact their doctor
AMA: Ruling Makes It Easier for Insurers to Terminate Doctors
Court supported insurance company in termination of doctors after dispute over necessity of services
Takayasu Arteritis, Ulcerative Colitis Co-Occurrence Rate High
6.4 percent of patients with TAK had UC; diseases share considerable proportion of genetic background
Psychological Features Impact Myofascial Paraspinous Pain Tx
Anxiety is strongest predictor of trigger point treatment response for patients with chronic pain
Psoriasis Patients at Higher Risk for Arrhythmia
Findings in patients with mild, severe disease and with/without psoriatic arthritis
Nonlinear Link for LDL, HDL With MACE Similar in RA, Non-RA
Nonlinear relationships seen in RA patients do not differ significantly from non-RA controls
FDA Issues Proposal on Lower-Cost, Generic Biotech Drugs
All biotech drugs to carry a four-letter code to distinguish brand name, generic versions
Too Few Blacks, Hispanics Pursuing Careers As Physicians
Shortage of minority physicians may affect U.S. patient care, experts say
